India to Belgium: Citalopram Export Trade Route
India has recorded 471 verified shipments of Citalopram exported to Belgium, representing a combined trade value of $12.0M USD. This corridor is served by 16 active Indian exporters, with an average shipment value of $25.6K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 80% of total export value with 161 shipments worth $9.6M USD. On the buying side, YUSEN LOGISTICS BENELUX BELGIUM is the largest importer in Belgium with $8.9M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, MICRO LABS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Belgium Citalopram corridor is one of India's established pharmaceutical export routes, with 471 shipments documented worth a combined $12.0M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's citalopram manufacturing sector.
Across 16 active suppliers, the average shipment value stands at $25.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with citalopram's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 16.0%, placing it at rank #16 among India's top citalopram export destinations globally.
On the import side, key buyers of Indian citalopram in Belgium include YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX BELGIUM , YUSEN LOGISTICS BENELUX BELGIUM. and 25 others. YUSEN LOGISTICS BENELUX BELGIUM is the single largest importer with 143 shipments valued at $8.9M USD.
